Aether Industries
- P/E
- 86.90
Key Fundamentals
SmallcapChemicals & PetrochemicalsChemicalsPrice-based figures as of · EPS basis: Consolidated · TTM
- ROCE
- 11.90%
- Debt to Equity
- 0.19
- EPS (TTM)
- ₹17.73
- Book Value
- ₹195.42
- Market Cap
- —
- P/E (TTM)
- 86.90
- P/B
- 7.88
- ROE
- 9.66%
- Dividend Yield
- 0.00%
- EBITDA
- ₹385 Cr
- 52W High
- ₹1,814.10
- 52W Low
- ₹728.00
- Day Range
- ₹1,491.20 – ₹1,551.00
- Volume
- 1,83,315
Peer Comparison
Commodities › Chemicals › Specialty Chemicals
| ₹1,510.20 | 58.04 | ₹1,54,107 Cr | 13.72 | 1.42% | 23.90% | 31.00% | ₹15,399 Cr | ₹2,677 Cr | |
| ₹4,613.30 | 83.76 | ₹49,073 Cr | 6.04 | 0.07% | 7.82% | 9.64% | ₹5,303 Cr | ₹600 Cr | |
| ₹8,785.00 | 57.03 | ₹44,060 Cr | 10.10 | 0.09% | 19.60% | 21.00% | ₹3,634 Cr | ₹789 Cr | |
| ₹1,578.40 | 27.48 | ₹20,919 Cr | 3.32 | 0.49% | 9.82% | 11.40% | ₹8,575 Cr | ₹784 Cr | |
| ₹1,540.70 | 86.90 | ₹20,030 Cr | 7.88 | 0.00% | 9.66% | 11.90% | ₹1,231 Cr | ₹235 Cr | |
| ₹447.55 | 30.57 | ₹15,838 Cr | 2.59 | 0.23% | 7.13% | 6.86% | ₹9,010 Cr | ₹531 Cr | |
| ₹5,156.50 | 19.67 | ₹14,827 Cr | 2.31 | 0.59% | 11.50% | 14.90% | ₹6,969 Cr | ₹788 Cr | |
| Median 7 companies | ₹1,578.40 | 57.03 | ₹20,919 Cr | 6.04 | 0.23% | 9.82% | 11.90% | ₹6,969 Cr | ₹784 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 98/100
Category scores
- Quality
- 40
- Weak
- Returns, margins, earnings quality 22% weight
- Valuation
- 14
- Poor
- Cheap vs sector & own history 24% weight
- Growth
- 98
- Strong
- Sales & profit trajectory 9% weight
- Financial Health
- 76
- Strong
- Solvency, leverage, coverage 9% weight
- Momentum
- 90
- Strong
- Trend strength, vol-adjusted 12% weight
- Ownership
- 51
- Average
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
1- Company is expected to give good quarter
Weaknesses
3- Stock is trading at 8.31 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 7.91% over last 3 years.
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Neutral | 6 | 7 | 6 |
| Oscillators | Neutral | 1 | 7 | 1 |
| Moving Averages | Neutral | 5 | 0 | 5 |
Oscillators
Neutral
Overall
Neutral
Moving Averages
Neutral
Key readings
- RSI (14)
- 45.77
- Neutral
- MACD (12,26,9)
- −33.65
- Bearish
- SMA (50)
- 1,634.40
- Bearish
- SMA (200)
- 1,305.55
- Bullish
As of
Analyst Rating
4 of 7 analysts rate Buy, 1 Hold, 2 Sell.
As of
Growth Rate
From the financial statements below. 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.
Revenue
| 3Y | +21.23% |
|---|---|
| 1Y | +37.93% |
| TTM | +34.39% |
Net profit
| 3Y | +18.99% |
|---|---|
| 1Y | +38.61% |
| TTM | +34.29% |
Operating cash flow
| 3Y | Turned positive |
|---|---|
| 1Y | +42.00% |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 3Y | +2.81 pp |
|---|---|
| 1Y | +2.49 pp |
| TTM | +0.79 pp |
Revenue by year
| Mar 2022 | ₹590 Cr |
|---|---|
| Mar 2023 | ₹651 Cr |
| Mar 2024 | ₹598 Cr |
| Mar 2025 | ₹841 Cr |
| Mar 2026 | ₹1,160 Cr |
Net profit by year
| Mar 2022 | ₹109 Cr |
|---|---|
| Mar 2023 | ₹130 Cr |
| Mar 2024 | ₹82.00 Cr |
| Mar 2025 | ₹158 Cr |
| Mar 2026 | ₹219 Cr |
Analyst Forecasts
AI Analysis — Bull vs Bear
Aether Industries Ltd trades at ₹1,521.8 as of 2026-11-02 with a market cap of ₹20,116 crore. The stock commands a premium valuation at 85.83x TTM P/E and 7.79x P/B, supported by strong revenue and profit growth of 34% and 30% TTM respectively, while maintaining a conservative balance sheet with a debt-to-equity ratio of 0.19.
- TTM sales growth of 34% indicates strong top-line momentum and rising demand for the company's specialty chemical products
- TTM profit growth of 30% demonstrates the company's ability to translate revenue gains into meaningful bottom-line expansion
- 3-year compounded sales CAGR of 21% reflects sustained, multi-year revenue growth rather than a one-off spike
- 3-year compounded profit CAGR of 20% shows consistent earnings compounding over a meaningful period
- Debt-to-equity ratio of just 0.19 indicates a conservatively financed balance sheet with limited leverage risk
- Stock has delivered a 1-year return CAGR of 106%, significantly outperforming broader market indices, with the price rising from a 52-week low of ₹728 to ₹1,521.8
- ROCE of 12.15% suggests the company generates reasonable returns on total capital deployed, supporting reinvestment-led growth
- The company is expected to deliver a good upcoming quarter, which could act as a near-term positive catalyst
- TTM P/E of 85.83x is extremely elevated, implying the stock prices in years of flawless execution and leaves minimal margin for earnings disappointment
- Stock trades at 8.31 times book value, a steep premium that demands consistently high growth to justify the valuation
- Zero dividend yield means shareholders receive no cash return; despite repeated profitability the company has chosen not to distribute any profits
- 3-year average ROE of approximately 8% is modest for a company commanding such premium multiples, suggesting capital is not being deployed at high-return rates
- Last year ROE of 10% and current ROE of 8.94% remain below the 15%+ levels typically expected of high-quality specialty chemical franchises trading at these valuations
- The stock is already 16.1% below its 52-week high of ₹1,814.1, indicating recent selling pressure even after a strong rally from the ₹728 low
- 3-year stock CAGR of 19% lags the TTM profit CAGR of 30%, suggesting returns have been volatile and back-end loaded rather than steady
- EPS of ₹17.73 TTM relative to the ₹1,521.8 share price means every rupee of current earnings is being valued at nearly ₹86, leaving significant downside risk if growth decelerates
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
TL;DR: Aether Industries delivered a strong Q2 FY27 with 26% profit growth and 24% revenue growth, driven by its CEM and CRAMS verticals which now contribute nearly two-thirds of revenue. Margins remain stable above 31% at the EBITDA level, and a lower tax rate provided an additional tailwind to net profitability. The trend is clearly improving, with CEM and CRAMS scaling toward the 70% revenue target, positioning Aether well for sustained specialty chemicals growth.
- Stock dips 2% post results Oct 30
Aether Industries shares traded around 2% lower following the Q2 FY27 results announcement, despite the strong earnings beat.
- LSM segment growth modest Oct 30
Large Scale Manufacturing showed only modest growth as production lines were strategically redeployed to the CEM business, with LSM accounting for part of the remaining ~34% of revenue outside CEM and CRAMS.
- Q2 profit jumps 26% YoY Oct 30
Net profit rose 26% YoY to ₹68 crore in Q2 FY27, while revenue from operations grew 24% to ₹347.2 crore. EBITDA expanded 25.6% to ₹110.4 crore with a stable 31.8% margin.
- CEM business surges 50% YoY Oct 30
The Contract Exclusive Manufacturing vertical recorded ~50.03% YoY growth, while CRAMS expanded ~23.91%, together contributing 65.97% of total revenue and tracking toward a 70% combined target.
- Sequential momentum continues Oct 30
Revenue rose 6.3% and net profit increased 8.4% quarter-on-quarter from Q1 FY27, demonstrating consistent sequential growth momentum.
- Shift toward higher-value segments Oct 30
Aether strategically redeployed certain production lines from LSM to the higher-growth CEM business, which now accounts for 33.35% of sales, reflecting a deliberate portfolio mix shift.
Quarterly Results
₹ Cr| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 161 | 164 | 155 | 118 | 180 | 199 | 220 | 240 | 257 | 280 | 319 | 305 | 327 | 347 |
| Expenses | 116 | 118 | 124 | 107 | 137 | 145 | 155 | 161 | 175 | 192 | 207 | 222 | 224 | 237 |
| Operating Profit | 45 | 46 | 31 | 10 | 43 | 54 | 65 | 80 | 81 | 88 | 112 | 83 | 103 | 110 |
| OPM % | 28% | 28% | 20% | 9% | 24% | 27% | 29% | 33% | 32% | 31% | 35% | 27% | 31% | 32% |
| Other Income | 2 | 14 | 5 | 4 | 9 | 8 | 11 | 2 | −1 | 6 | −4 | 10 | 8 | 5 |
| Interest | 1 | 2 | 2 | 4 | 3 | 2 | 3 | 5 | 5 | 3 | 4 | 6 | 6 | 5 |
| Depreciation | 9 | 10 | 10 | 10 | 10 | 11 | 11 | 13 | 14 | 17 | 17 | 18 | 21 | 22 |
| PBT | 37 | 49 | 24 | 0 | 39 | 49 | 61 | 64 | 62 | 74 | 87 | 68 | 83 | 89 |
| Tax % | 19% | 25% | 27% | 486% | 24% | 28% | 29% | 21% | 24% | 27% | 26% | 21% | 25% | 23% |
| Net Profit | 30 | 37 | 17 | −1 | 30 | 35 | 43 | 50 | 47 | 54 | 64 | 54 | 63 | 68 |
| EPS (₹) | 2.25 | 2.77 | 1.31 | −0.11 | 2.26 | 2.63 | 3.27 | 3.79 | 3.55 | 4.07 | 4.86 | 4.07 | 4.73 | — |
Sep 2026: from the results filed on 30 Oct 2026, ahead of the full statement, so some rows are blank.
Profit & Loss
₹ Cr| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|
| Sales | 590 | 651 | 598 | 841 | 1,160 | 1,231 |
| Expenses | 422 | 465 | 466 | 598 | 796 | 845 |
| Operating Profit | 168 | 186 | 132 | 243 | 364 | 386 |
| OPM % | 28% | 29% | 22% | 29% | 31% | 31% |
| Other Income | 7 | 17 | 25 | 28 | 12 | 20 |
| Interest | 13 | 5 | 9 | 13 | 18 | 19 |
| Depreciation | 15 | 23 | 40 | 45 | 66 | 74 |
| PBT | 146 | 174 | 110 | 213 | 291 | 313 |
| Tax % | 26% | 25% | 25% | 26% | 25% | — |
| Net Profit | 109 | 130 | 82 | 158 | 219 | 235 |
| EPS (₹) | 9.67 | 10.47 | 6.22 | 11.95 | 16.54 | 17.73 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Equity Capital | 113 | 125 | 133 | 133 | 133 |
| Reserves | 274 | 1,120 | 1,931 | 2,093 | 2,323 |
| Borrowings | 291 | 16 | 183 | 200 | 458 |
| Other Liabilities | 92 | 120 | 154 | 218 | 288 |
| Total Liabilities | 770 | 1,380 | 2,401 | 2,644 | 3,201 |
| Fixed Assets | 257 | 646 | 853 | 1,117 | 1,496 |
| CWIP | 58 | 37 | 232 | 363 | 516 |
| Investments | 17 | 1 | 0 | 0 | 0 |
| Other Assets | 438 | 695 | 1,315 | 1,163 | 1,189 |
| Total Assets | 770 | 1,380 | 2,401 | 2,644 | 3,201 |
Cash Flow
₹ Cr| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating | −5 | −7 | −16 | 100 | 142 |
| Investing | −151 | −348 | −424 | −418 | −619 |
| Financing | 169 | 439 | 894 | 1 | 244 |
| Net Cash Flow | 12 | 84 | 453 | −317 | −233 |
| Free Cash Flow | −157 | −363 | −444 | −352 | −481 |
| CFO/EBITDA | 17 | 14 | 1 | 64 | 54 |
Ratios
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debtor Days | 101 | 145 | 142 | 125 | 123 |
| Inventory Days | 221 | 301 | 411 | 356 | 345 |
| Days Payable | 95 | 99 | 124 | 114 | 126 |
| Cash Conversion Cycle | 227 | 348 | 429 | 367 | 341 |
| Working Capital Days | 82 | 268 | 279 | 239 | 160 |
| ROCE % | — | 18% | 7% | 10% | 12% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Aether Industries insights
60 extracted metrics across FY18–FY27.
Documents
- Q1 FY27 concall · Aug 2026Transcript PPT Recording
- Q1 FY27 concall · Jul 2026PPT
- Q4 FY26 concall · May 2026Transcript PPT Recording
- Q3 FY26 concall · Feb 2026Transcript PPT
- 15 Oct 2026
- 23 Sep 2026
- 26 May 2026
- 30 Sep 2025
- 10 Jan 2025
- General announcements 3 Nov 2026
Frequently Asked Questions about Aether Industries
What does Aether Industries Ltd do?
Where is Aether Industries Ltd (AETHER) listed?
Which sector does Aether Industries Ltd belong to?
What is the PE ratio of Aether Industries Ltd?
What is the 52-week high and low of Aether Industries Ltd?
What is the Return on Equity (ROE) of Aether Industries Ltd?
Company Information
Incorporated in 2013, Aether Industries Limited is a manufacturer of specialty chemicals. The company is sole Indian manufacturer for chemicals such as 4-(2-Methoxyethyl) Phenol (4MEP), and 3-Methoxy-2-Methylbenzoyl Chloride (MMBC), Thiophene-2-Ethanol (T2E), Ortho Tolyl Benzo Nitrile (OTBN), N-Octyl-D-Glucamine, Delta-Valerolactone, and Bifenthrin Alcohol.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/AETHER.md for Aether Industries Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.